계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Cipher Pharmaceuticals
company
About
A rapidly growing specialty pharmaceutical dermatology company with a diversified portfolio of commercial-stage products
- 51 - 100
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $20M
- Industries
- Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2000
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Cipher Pharmaceuticals is a specialty pharmaceutical company that develops improved formulations of existing drugs. They search for products in defined markets to in-license into our pipeline. These products are based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance. Their core competency is identifying these product opportunities and managing their clinical and regulatory development. Finally, we harvest the rewards by out-licensing to partners and generating royalty streams.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20M
Cipher Pharmaceuticals has raised a total of
$20M
in funding over 2 rounds. Their latest funding was raised on
Nov 3, 2017 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 3, 2017 | Post-IPO Debt | $20M | 1 |
CIBC
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Cipher Pharmaceuticals is funded by 1 investors.
CIBC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
CIBC
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
